BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomé-Castro XM, Rodriguez-Arrastia M, Cardona D, Rueda-Ruzafa L, Molina-Torres G, Roman P. Probiotics as a therapeutic strategy in obesity and overweight: a systematic review. Benef Microbes 2021;12:5-15. [PMID: 33459204 DOI: 10.3920/BM2020.0111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Arabi SM, Bahrami LS, Rahnama I, Sahebkar A. Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2022;176:106061. [PMID: 34999222 DOI: 10.1016/j.phrs.2022.106061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Mallappa RH, Balasubramaniam C, Amarlapudi MR, Kelkar S, Adewumi GA, Kadyan S, Pradhan D, Grover S. Role of probiotics in the prevention and management of diabetes and obesity. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00006-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Garcia-gutierrez E, Sayavedra L. Diet, Microbiota and the Gut-Brain Axis. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00089-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Maioli TU, Borras-Nogues E, Torres L, Barbosa SC, Martins VD, Langella P, Azevedo VA, Chatel JM. Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders. Front Pharmacol 2021;12:740636. [PMID: 34925006 DOI: 10.3389/fphar.2021.740636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]